Proterra Inc. Securities Litigation Settlement
This settlement is closed to new claims — the deadline was August 29, 2025. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Proterra Inc. and its defendants are settling securities litigation brought by shareholders who claim they were harmed by alleged misconduct related to Proterra's business combination with ArcLight Clean Transition Corp. and subsequent stock sales. The defendants are paying $29 million to resolve all claims without admitting wrongdoing.
Do you qualify?
Anyone who purchased or acquired Proterra Inc. public shares through the May 14, 2021 proxy/registration statement relating to the ArcLight business combination, or who purchased Proterra common stock between August 11, 2021 and August 7, 2023. Excluded are defendants, their families, former directors, and affiliated entities.
How to file
Submit a Claim Form with required supporting documentation online through the website or by mail to the Claims Administrator. Claims and documentation must be received or postmarked no later than August 29, 2025.
Common questions
- How much does the Proterra Inc. Securities Litigation Settlement pay?
- The total settlement fund is $29M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the Proterra Inc. Securities Litigation Settlement?
- This settlement is closed to new claims — the deadline was August 29, 2025. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the Proterra Inc. Securities Litigation Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the Proterra Inc. Securities Litigation Settlement notice real, or a scam?
- Claims Administrator (not named) is the settlement administrator for this case. Claims are filed at proterrasecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Proterra Inc. Securities Litigation Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for August 20, 2025; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.